Sistema mulls selling 20% in Medsi to foreign investors, RDIF

MOSCOW, Feb 28 (PRIME) -- Multi-industry holding Sistema is discussing sales of 20% in healthcare facilities chain Medsi with investors from Japan, China, the Arab countries, and the Russian Direct Investment Fund (RDIF), Sistema’s Managing Partner and Chairman of Medsi’s Board of Director Artyom Sirazutdinov told PRIME on Thursday.

“Given great dynamics of the company’s development, investors from Japan, China, and the Arab countries express active interest in Medsi. They are discussing a possibility of buying up to 20% in Medsi from Sistema. We are also discussing this issue with the RDIF,” he said.

“The company has been demonstrating growth of financial and operating figures for two years straight. We expect this trend to continue, and Medsi will be able to raise its revenue and improve its share on the Russian market significantly, to 5% in the next three years. In 2019, the company plans to expand its presence in Moscow and the Moscow Region, and to enter at least two new regions,” he said.

In January, RDIF CEO Kirill Dmitriev said that the fund may buy minority stakes in Sistema’s units Medsi, pulp and paper holding Segezha, and agricultural holding Steppe.

Medsi runs 19 clinics in Moscow and the Moscow Region, 12 clinics, three diagnostic and treatment centers, two hospitals, and 70 medical stations in regions of Russia, fitness and wellness centers, and two health resort facilities.

End